Statements (75)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:GAVI_Alliance
gptkb:GAVI gptkb:Crucell gptkb:GAVI,_the_Vaccine_Alliance gptkb:Gavi gptkb:cervical_cancer |
| gptkbp:appointed_by |
adolescents
young women intramuscular injection young men three doses |
| gptkbp:approves |
gptkb:2006
gptkb:FDA |
| gptkbp:can_be_extended_by |
females
males |
| gptkbp:contains |
virus-like particles
|
| gptkbp:developed_by |
gptkb:Merck_&_Co.
gptkb:Glaxo_Smith_Kline |
| https://www.w3.org/2000/01/rdf-schema#label |
HPV vaccine
|
| gptkbp:investment |
gptkb:cervical_cancer
genital warts |
| gptkbp:is_associated_with |
increased vaccination rates
decreased healthcare costs decreased incidence of HPV-related cancers |
| gptkbp:is_available_in |
multiple formulations
|
| gptkbp:is_available_on |
schools
healthcare providers vaccination clinics |
| gptkbp:is_considered |
safe and effective
a public health success a key tool in cancer prevention |
| gptkbp:is_effective_against |
high-risk HPV types
low-risk HPV types certain strains of human papillomavirus |
| gptkbp:is_evaluated_by |
post-marketing studies
safety assessments efficacy studies longitudinal studies cost-effectiveness analyses |
| gptkbp:is_linked_to |
improved quality of life
improved public health outcomes increased awareness of sexual health increased awareness of HPV decreased mortality from cervical cancer increased screening for cervical cancer reduction in HPV transmission |
| gptkbp:is_part_of |
public health initiatives
preventive healthcare women's health initiatives cancer prevention strategies school health programs men's health initiatives global health strategies adolescent health programs comprehensive sexual education programs routine vaccination schedule |
| gptkbp:is_promoted_by |
gptkb:educational_campaigns
non-profit organizations community outreach health organizations media campaigns government health agencies |
| gptkbp:is_subject_to |
clinical trials
regulatory oversight health policy discussions |
| gptkbp:requires |
informed consent
|
| gptkbp:suitable_for |
gptkb:CDC
gptkb:WHO young adults pregnant individuals individuals with severe allergies to components preteens |
| gptkbp:targets |
gptkb:healthcare_organization
|